Department of Cardiology, Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, England, United Kingdom (A.H., M.M., C.R., A.S., M.S., D.T., M.H., S.M., R.S., D.G.).
Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom (M.D.).
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006576. doi: 10.1161/CIRCEP.118.006576.
Background Catheter ablation for persistent atrial fibrillation (AF) is associated with less favorable outcomes than for paroxysmal AF. Substrate modification is often added to pulmonary vein isolation (PVI) to try to improve success rates. Recent studies have shown improved clinical outcomes with use of regional ablation index (AI) targets for PVI. We hypothesized that prospective use of AI-guided PVI in persistent AF patients would result in a low rate of PV reconnection at repeat electrophysiology study and that a high success rate can be achieved with durable PVI alone. Methods Forty consecutive patients with persistent AF underwent AI-guided PVI with target values of 550 for anterior and 400 for posterior left atrial regions, followed by a protocol-mandated repeat procedure after 2 months. Patients were monitored for atrial tachyarrhythmia recurrence via daily plus symptom-initiated ECG recordings for 12 months. Recurrence was defined as ≥30 seconds of any atrial tachyarrhythmia after a 3-month blanking period. Results PV reconnection was seen at repeat electrophysiology study in 22% of patients, affecting 7% of PVs. Ablation on the intervenous carina was required in 44% patients to achieve durable PVI. Atrial tachyarrhythmia recurrence was documented in 8 (20%) patients, only one of whom had PV reconnection at repeat study. At 12 months, 38/40 (95%) patients were in sinus rhythm, with 4 (10%) patients having started antiarrhythmic drugs. Higher body mass index and excess alcohol consumption were the only significant factors associated with atrial tachyarrhythmia recurrence. Conclusions Use of AI targets results in a high level of durable PVI. A good clinical outcome can be achieved in the great majority of persistent AF patients with AI-guided PVI alone. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT02628730.
持续性心房颤动(AF)的导管消融治疗效果不如阵发性 AF。为了提高成功率,通常在肺静脉隔离(PVI)的基础上进行基质修饰。最近的研究表明,使用区域性消融指数(AI)目标进行 PVI 可以改善临床结果。我们假设在持续性 AF 患者中前瞻性地使用 AI 指导的 PVI 将导致在重复电生理研究中 PV 再连接的发生率较低,并且单独使用持久的 PVI 可以实现高成功率。
40 例持续性 AF 患者接受 AI 指导的 PVI,左心房前区目标值为 550,后区目标值为 400,然后在 2 个月后进行协议规定的重复程序。通过每天加症状触发的心电图记录对患者进行 12 个月的房性快速心律失常复发监测。在 3 个月的空白期后,任何房性快速心律失常持续≥30 秒定义为复发。
在 22%的患者中,在重复电生理研究中观察到 PV 再连接,影响 7%的 PV。44%的患者需要在静脉嵴间消融以实现持久的 PVI。有 8 例(20%)患者记录到房性快速心律失常复发,只有 1 例在重复研究中出现 PV 再连接。12 个月时,40 例患者中的 38 例(95%)处于窦性心律,其中 4 例(10%)开始使用抗心律失常药物。较高的体重指数和过量饮酒是与房性快速心律失常复发唯一显著相关的因素。
使用 AI 目标可实现高水平的持久 PVI。在大多数持续性 AF 患者中,单独使用 AI 指导的 PVI 即可获得良好的临床效果。